1 December 2023 - Two small RCTs with children of different ages together make it possible to make one statement: the ...
28 January 2022 - This article aims at describing the most relevant elements of the drug development process in the paediatric ...
20 January 2022 - The Federal Joint Committee (G-BA) today classified the additional benefit of the active ingredient blinatumomab as significant ...
3 December 2020 - Inappropriate treatment in the control arm makes fair comparison impossible. ...
15 January 2020 - Weak evidence does not allow a specific statement to be made about the extent of the added ...
12 Septemner 2018 - Novartis' breakthrough cancer drug Kymriah has been approved in Europe. Now comes the debate about its ...
1 April 2016 - Under the trade name Edurant, rilpivirine hydrochloride as single agent has been approved already since 2011 for ...